C10ORF55 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with C10ORF55 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with C10ORF55 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with C10ORF55 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with C10ORF55 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000118729 - calsequestrin 2

Gene

ENSG00000204852 - tectonic family member 1

Gene

ENSG00000196296 - ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

Gene

ENSG00000010322 - nischarin

Gene

ENSG00000151779 - NBAS subunit of NRZ tethering complex

Gene

ENSG00000172399 - myozenin 2

Gene

ENSG00000169902 - tyrosylprotein sulfotransferase 1

Gene

ENSG00000008838 - mediator complex subunit 24

Gene

ENSG00000086967 - myosin binding protein C2

  • Gene

    ENSG00000118729 - calsequestrin 2


  • Gene

    ENSG00000204852 - tectonic family member 1


  • Gene

    ENSG00000196296 - ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1


  • Gene

    ENSG00000010322 - nischarin


  • Gene

    ENSG00000151779 - NBAS subunit of NRZ tethering complex


  • Gene

    ENSG00000172399 - myozenin 2


  • Gene

    ENSG00000169902 - tyrosylprotein sulfotransferase 1


  • Gene

    ENSG00000008838 - mediator complex subunit 24


  • Gene

    ENSG00000086967 - myosin binding protein C2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.